Curb Compulsive Eating Naturally
Novel Spice Extract Targets the Neurochemistry of AppetiteAugust 2010
By Julius Goepp, MD
The Depression Connection
Based on the findings of Bourges’s team, it has been proposed that saffron extracts might inhibit serotonin reuptake in synapses. Inhibiting synaptic serotonin reuptake keeps this mood-elevating neurotransmitter in the brain longer, enhancing its effects and combating depression. This proposed mechanism is supported by recent animal studies demonstrating antidepressant properties in extracts of multiple parts of the saffron plant.27
Saffron extracts have also demonstrated efficacy in managing mild to moderate depression and anxiety in humans 24,27-29—the same disorders that drive emotional eating. This affords a novel alternative to antidepressant drugs.
Extracts of saffron have been proven superior to placebo for management of mild to moderate depression in a number of controlled clinical trials, consistently producing better outcomes on the standard Hamilton depression rating scale.28,30 Saffron extracts also outperformed placebo in a related study of premenstrual syndrome.31 (The premenstrual phase is often accompanied by depressed mood and caloric overconsumption.)32
Even more compelling are the comparative data on saffron and prescription antidepressants. In one study, just 30 mg of standardized saffron extract delivering active constituents such as safranal and crocin produced results similar to 100 mg of the tricyclic antidepressant imipramine.33 The same amount of saffron extract produced results identical to the popular selective serotonin reuptake inhibitor (SSRI) fluoxetine (Prozac®) in separate trials.34,35 Saffron produced no side effects, while the antidepressants produced a familiar list of adverse effects, including dry mouth and sedation.32
Emotional and compulsive eating have ties to anxiety, as well as depression. Animal studies show that safranal possesses anti-anxiety (anxiolytic) properties without affecting coordination or motor activity.24 One pre-clinical model found that saffron extracts were as effective as diazepam (Valium®) at reducing manifestations of anxiety.29
A complementary body of research indicates a positive role for saffron extracts containing safranal as an optimal intervention for stress and anxiety—core factors in the development of eating compulsions.
Natural Anxiety and Stress Control
Treating anxiety with benzodiazepines like Valium® (diazepam) may be temporarily effective, but it produces significant side effects, among them impaired memory.36 In contrast, saffron extracts not only reduce the depression and anxiety that can lead to emotional eating—they prevent memory impairment.37 In fact, saffron extracts have been shown to enhance memory.38
Scientists have developed a working understanding of how saffron produces these effects in the brain. Active extracts of saffron increase so-called long-term potentiation, the electrochemical mechanism underlying learning and memory at the cellular level.39 This effect has proven powerful enough to protect experimental animals’ brains from alcohol-induced memory loss.40,41 By an entirely different set of mechanisms, saffron extracts also protect brain cells in culture from inflammatory damage and death induced by cytokines such as TNF-alpha.42
Interestingly, advances in our understanding of stress and anxiety reveal that they are accompanied by increased oxidative stress in brain cells.43 Earlier this year, scientific evidence emerged indicating that oxidative stress in the brain is also a positive marker for compulsive behavior.44 Accordingly, there’s evidence that saffron’s capacity to limit emotional eating may be related to its antioxidant capacity.45,46
A historic 2010 study conclusively demonstrated that the neurochemical processes behind compulsive eating and drug addiction are identical—suggesting a novel neurological intervention for appetite control. While no safe, effective drug exists to favorably alter the neurochemistry of appetite, a proprietary saffron extract has been shown to reduce uncontrolled “between-meal” snacking without side effects.
At the core of saffron’s power is a scientifically validated ability to boost levels of serotonin, reducing the depression, anxiety, and stress central to compulsive eating. These effects, prized in traditional Persian medicine and corroborated by a team of pioneering French researchers, have been shown to be equal in potency to the tricyclic imipramine and the SSRI fluoxetine (Prozac®) in managing depression. By targeting the neurochemistry at the root of compulsive eating behavior, saffron extract serves as a safe, natural way to reduce caloric intake and induce weight loss.
If you have any questions on the scientific content of this article, please call a Life Extension® Health Advisor at 1-866-864-3027.
1. Johnson PM, Kenny, PJ. Dopamine D2 receptors in addiction-like reward dysfunction and compulsive eating in obese rats. Nat Neurosci. 2010 May;13(5):635-41.
2. Available at: http://www.sciencedaily.com/releases/2010/03/100328170243.htm. Accessed May 18, 2010.
3. Rodgers RJ, Holch P, Tallett AJ. Behavioural satiety sequence (BSS): Separating wheat from chaff in the behavioural pharmacology of appetite. Pharmacol Biochem Behav. 2010 Mar 7.
4. Connolly HM, Crary JL, McGoon MD, Hensrud DD, Edwards BS, Edwards WD, Schaff HV. Valvular heart disease associated with fenfluramine-phentermine. N Engl J Med. 1997 Aug 28;337(9):581-8.
5. Adamson MW. Food in Medieval Times. Greenwood Publishing; 2004.
6. Kafi MM, Koocheki A, Rashed MH (eds). Saffron (Crocus sativus) Production and Processing. Science Publishers; 2006.
7. Fetissov SO, Meguid MM. Serotonin delivery into the ventromedial nucleus of the hypothalamus affects differently feeding pattern and body weight in obese and lean Zucker rats. Appetite. 2010 Apr;54(2):346-53.
8. Przegalinski E, Gołda A, Filip M. Effects of serotonin (5-HT)(1B) receptor ligands on cocaine-seeking behavior in rats. Pharmacol Rep. 2008 Nov-Dec;60(6):798-810.
9. Breum L, Rasmussen MH, Hilsted J, Fernstrom JD. Twenty-four-hour plasma tryptophan concentrations and ratios are below normal in obese subjects and are not normalized by substantial weight reduction. Am J Clin Nutr. 2003 May;77(5):1112-8.
10. Gendall KA, Joyce PR. Meal-induced changes in tryptophan:LNAA ratio: effects on craving and binge eating. Eat Behav. 2000 Sep;1(1):53-62.
11. Cangiano C, Ceci F, Cascino A, et al. Eating behavior and adherence to dietary prescriptions in obese adult subjects treated with 5-hydroxytryptophan. Am J Clin Nutr.1992 Nov;56(5):863-7.
12. Cangiano C, Laviano A, Del Ben M, et al. Effects of oral 5-hydroxy-tryptophan on energy intake and macronutrient selection in non-insulin dependent diabetic patients. Int J Obes Relat Metab Disord.1998 Jul;22(7):648-54.
13. Alger S, Seagle H, Ravussin E. Food intake and energy expenditure in obese female bingers and non-bingers. Int J Obes Relat Metab Disord. 1995 Jan;19(1):11-6.
14. Elfhag K, Morey LC. Personality traits and eating behavior in the obese: poor self-control in emotional and external eating but personality assets in restrained eating. Eat Behav. 2008 Aug;9(3):285-93.
15. Alger S, Seagle H, Ravussin E. Food intake and energy expenditure in obese female bingers and non-bingers. Int J Obes Relat Metab Disord. 1995 Jan;19(1):11-6.
16. Konttinen H, Mannisto S, Sarlio-Lahteenkorva S, Silventoinen K, Haukkala A. Emotional eating, depressive symptoms and self-reported food consumption. A population-based study. Appetite. 2010 Feb 4.
17. van Strien T, van der Zwaluw CS, Engels RC. Emotional eating in adolescents: A gene (SLC6A4/5-HTT) - Depressive feelings interaction analysis. J Psychiatr Res. 2010 Apr 21.
18. Clarke H, Flint J, Attwood AS, Munafo MR. Association of the 5- HTTLPR genotype and unipolar depression: a meta-analysis. Psychol Med. 2010 Apr 12:1-12.
19. Furman DJ, Hamilton JP, Joormann J, Gotlib IH. Altered timing of amygdala activation during sad mood elaboration as a function of 5-HTTLPR. Soc Cogn Affect Neurosci. 2010 Apr 1.
20. Brocke B, Armbruster D, Muller J, et al. Serotonin transporter gene variation impacts innate fear processing: Acoustic startle response and emotional startle. Mol Psychiatry. 2006 Dec;11(12):1106-12.
21. Hemels ME, Koren G, Einarson TR. Increased use of antidepressants in Canada: 1981-2000. Ann Pharmacother. 2002 Sep;36(9):1375-9.
22. Zimmerman M, Galione JN, Attiullah N, et al. Underrecognition of clinically significant side effects in depressed outpatients. J Clin Psychiatry. 2010 Apr;71(4):484-90.
23. Lee KU, Lee YM, Nam JM, et al. Antidepressant-induced sexual dysfunction among newer antidepressants in a naturalistic setting. Psychiatry Investig. 2010 Mar;7(1):55-9.
24. Hosseinzadeh H, Noraei NB. Anxiolytic and hypnotic effect of Crocus sativus aqueous extract and its constituents, crocin and safranal, in mice. Phytother Res. 2009 Jun;23(6):768-74.
25. Noury J, Bourges C. Enquête sur l’impact du complément alimentaire SATIEREAL chez des femmes ayant une tendance à l’hyperphagie réflexe non pathologique: Nutraveris; 2006.
26. Gout B, Bourges C. Efficacy and safety of an 8-week oral supplementation with a Crocus sativus stigma extract on weight loss, satiety and snacking reduction: a prospective, randomized, double-blind, placebo-controlled trial in healthy women with moderate overweight. In press. 2010.
27. Wang Y, Han T, Zhu Y, et al. Antidepressant properties of bioactive fractions from the extract of Crocus sativus L. J Nat Med. 2010 Jan;64(1):24-30.
28. Moshiri E, Basti AA, Noorbala AA, Jamshidi AH, Hesameddin Abbasi S, Akhondzadeh S. Crocus sativus L. (petal) in the treatment of mild-to-moderate depression: a double-blind, randomized and placebo-controlled trial. Phytomedicine. 2006 Nov;13(9-10):607-11.
29. Pitsikas N, Boultadakis A, Georgiadou G, Tarantilis PA, Sakellaridis N. Effects of the active constituents of Crocus sativus L., crocins, in an animal model of anxiety. Phytomedicine. 2008 Dec;15(12):1135-9.
30. Akhondzadeh S, Tahmacebi-Pour N, Noorbala AA, et al. Crocus sativus L. in the treatment of mild to moderate depression: a double-blind, randomized and placebo-controlled trial. Phytother Res. 2005 Feb;19(2):148-51.
31. Agha-Hosseini M, Kashani L, Aleyaseen A, et al. Crocus sativus L. (saffron) in the treatment of premenstrual syndrome: a double-blind, randomised and placebo-controlled trial. BJOG. 2008 Mar;115(4):515-9.
32. Dye L, Blundell JE. Menstrual cycle and appetite control: implications for weight regulation. Hum Reprod. 1997 Jun;12(6):1142-51.
33. Akhondzadeh S, Fallah-Pour H, Afkham K, Jamshidi AH, Khalighi-Cigaroudi F. Comparison of Crocus sativus L. and imipramine in the treatment of mild to moderate depression: a pilot double-blind randomized trial [ISRCTN45683816]. BMC Complement Altern Med. 2004 Sep 2;4:12.
34. Noorbala AA, Akhondzadeh S, Tahmacebi-Pour N, Jamshidi AH. Hydro-alcoholic extract of Crocus sativus L. versus fluoxetine in the treatment of mild to moderate depression: a double-blind, randomized pilot trial. J Ethnopharmacol. 2005 Feb 28;97(2):281-4.
35. Akhondzadeh Basti A, Moshiri E, Noorbala AA, Jamshidi AH, Abbasi SH, Akhondzadeh S. Comparison of petal of Crocus sativus L. and fluoxetine in the treatment of depressed outpatients: a pilot double-blind randomized trial. Prog Neuropsychopharmacol Biol Psychiatry. 2007 Mar 30;31(2):439-42.
36. Uzun S, Kozumplik O, Jakovljevic M, Sedic B. Side effects of treatment with benzodiazepines. Psychiatr Danub. 2010 Mar;22(1):90-3.
37. Pitsikas N, Sakellaridis N. Crocus sativus L. extracts antagonize memory impairments in different behavioural tasks in the rat. Behav Brain Res. 2006 Oct 2;173(1):112-5.
38. Pitsikas N, Zisopoulou S, Tarantilis PA, Kanakis CD, Polissiou MG, Sakellaridis N. Effects of the active constituents of Crocus sativus L., crocins on recognition and spatial rats’ memory. Behav Brain Res. 2007 Nov 2;183(2):141-6.
39. He WB, Zhang JL, Xue W, Hu JF, Wu DH, Chen NH. Comparison of the action of isolichenin and methanol extract of saffron on long-term potentiation in hippocampal dentate gyrus in vivo. Yao Xue Xue Bao. 2009 Aug;44(8):858-62.
40. Abe K, Saito H. Effects of saffron extract and its constituent crocin on learning behaviour and long-term potentiation. Phytother Res. 2000 May;14(3):149-52.
41. Zhang Y, Shoyama Y, Sugiura M, Saito H. Effects of Crocus sativus L. on the ethanol-induced impairment of passive avoidance performances in mice. Biol Pharm Bull. 1994 Feb;17(2):217-21.
42. Soeda S, Ochiai T, Paopong L, Tanaka H, Shoyama Y, Shimeno H. Crocin suppresses tumor necrosis factor-alpha-induced cell death of neuronally differentiated PC-12 cells. Life Sci. 2001 Nov 2;69(24):2887-98.
43. Bouayed J, Rammal H, Soulimani R. Oxidative stress and anxiety: Relationship and cellular pathways. Oxid Med Cell Longev. 2009 Apr;2(2):63-7.
44. Behl A, Swami G, Sircar SS, Bhatia MS, Banerjee BD. Relationship of possible stress-related biochemical markers to oxidative/antioxidative status in obsessive-compulsive disorder. Neuropsychobiology. 2010;61(4):210-4.
45. Premkumar K, Abraham SK, Santhiya ST, Ramesh A. Protective effects of saffron (Crocus sativus Linn.) on genotoxins-induced oxidative stress in Swiss albino mice. Phytother Res. 2003 Jun;17(6):614-7.
46. Ochiai T, Ohno S, Soeda S, Tanaka H, Shoyama Y, Shimeno H. Crocin prevents the death of rat pheochromyctoma (PC-12) cells by its antioxidant effects stronger than those of alpha-tocopherol. Neurosci Lett. 2004 May 13;362(1):61-4.